Case Report: Mature tertiary lymphoid structures in a metastatic urothelial carcinoma patient with an exceptional response to sequential immune checkpoint inhibitor and antibody-drug conjugate therapy.
- DOI
- 10.3389/fonc.2026.1907498
- Published
- 2026
- Container
- Frontiers in oncology
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.3389/fonc.2026.1907498,
title = {Case Report: Mature tertiary lymphoid structures in a metastatic urothelial carcinoma patient with an exceptional response to sequential immune checkpoint inhibitor and antibody-drug conjugate therapy.},
author = {Hori K and Ogasawara T and Mizue Y and Asanuma H and Shijubou N and Yamashita A and Kato R and Furumido J and Abe T and Sato K and Hirohashi Y},
year = {2026},
journal = {Frontiers in oncology},
doi = {10.3389/fonc.2026.1907498},
url = {https://doi.org/10.3389/fonc.2026.1907498}
}RIS
TY - JOUR TI - Case Report: Mature tertiary lymphoid structures in a metastatic urothelial carcinoma patient with an exceptional response to sequential immune checkpoint inhibitor and antibody-drug conjugate therapy. AU - Hori K AU - Ogasawara T AU - Mizue Y AU - Asanuma H AU - Shijubou N AU - Yamashita A AU - Kato R AU - Furumido J AU - Abe T AU - Sato K AU - Hirohashi Y PY - 2026 JO - Frontiers in oncology DO - 10.3389/fonc.2026.1907498 UR - https://doi.org/10.3389/fonc.2026.1907498 ER -
APA
K, H., T, O., Y, M., H, A., N, S., A, Y., R, K., J, F., T, A., K, S., & Y, H. (2026). Case Report: Mature tertiary lymphoid structures in a metastatic urothelial carcinoma patient with an exceptional response to sequential immune checkpoint inhibitor and antibody-drug conjugate therapy.. Frontiers in oncology. https://doi.org/10.3389/fonc.2026.1907498
Source records
- pubmed · retrieved 2026-09-26T18:43:29.480Z